| This week's sponsor is Premier Research. | |  | Taking the Fight to Rare Cancers
Beating rare cancers demands expertise in oncology and rare diseases. Our white paper shows how adaptive design, study committees, and cross-industry cooperation are fueling real progress. Premier Research. Built for biotech. |
Today's Rundown Featured Story | | | Tuesday, September 10, 2019 BioNTech has filed to raise $100 million n a Nasdaq IPO. The proposal would set BioNTech up to run clinical trials of three mRNA assets while funding its share of collaborations with Genentech, Sanofi and Genmab. |
|
|---|
|
Top Stories Tuesday, September 10, 2019 Investors may gauge a biotech IPO by how much it raised and how much the stock appreciates, but the true measure of success is simple: What did it achieve with the cash? Here, we take a look at biotechs that went public and got a drug to market, as well as those that fizzled after their IPO. Tuesday, September 10, 2019 Kleiner Perkins and GV have powered Trucode Gene Repair to a $34 million financing round. Trucode will use the money to advance gene editing assets designed to correct the mutations behind diseases including sickle cell and cystic fibrosis. Monday, September 9, 2019 Patients want the best cancer therapies, and sites that enable clinical trials are the ones that can access those new drugs faster. Here’s how Tuesday, September 10, 2019 After steering Spark's Luxturna through FDA approval and launch, COO John Furey left the gene therapy biotech and spent time on some biotech advisory boards. Now, he's heading Imvax, which is working on a vaccine for brain cancer. Tuesday, September 10, 2019 Jochen Knolle, the inventor of Firazyr, is at it again. After shepherding the injected HAE med through approval, he's founded a new company around an oral treatment for the disease. Pharvaris raised $66 million in series B financing to ramp up the clinical development of the drug. Tuesday, September 10, 2019 Pfizer is developing its 20-valent pneumococcal vaccine as a follow-up to Prevnar 13, and on Monday released positive preliminary data in infants. But it's jockeying against Merck & Co., which already has a lead in the same group of patients. Enrollment Showcase | | | October 23-25, 2019 | Chicago, IL | Presented by Biotech Primer BioImmersion: Biotech for the Non-Scientist is a three-day, in-depth course that delves into the scientific details on a broad number of biotechnology topics. Register today! |
|
|---|
|
Resources Sponsored by: Patheon, by Thermo Fisher Scientific Avoid potential risks to the patient as well as costly interruptions during development. Sponsored by: Outer Edge Technology Find out how outsourcing your IT requirements enhances the bottom line while creating strategic advantage. Sponsored by: Vineti Developing a cell therapy, gene therapy, or personalized cancer vaccine? Modern data management makes a critical difference in operational and regulatory outcomes. This whitepaper will help your team leverage the latest data strategies for success. Sponsored by: AlphaSense AI-powered research tools are making it easier to source confident healthcare market intelligence with accuracy and efficiency -- download now to learn more about improving your competitive research strategy. Sponsored by: Elemental Machines Your lab is talking to you, are you listening? Sponsored by: Frenova Want to be sure your renal research protocol design is fit for the real world? Sponsored by: Recro Gainesville Vetting CDMOs but unsure what to look for in prospective partners’ multiproduct facilities? Sponsored by: Accenture Clinical trials are one of the pharma industry’s most painful and costly processes. Read how technology could transform the trial process from nine years to a matter of hours. Sponsored by: Baxter BioPharma Solutions Check out Baxter BioPharma Solutions’ whitepaper to learn considerations and options for developing a product in a prefilled syringe. Sponsored by: Alexander Group From sales headcount and budgets to new product launches and saying “yes” to millennials, hear the top 7 topics that are trending in sales compensation. Sponsored by: Wesco Pharmaceutical Solutions and WBR Insights The regulations and managing processes for hazardous, controlled and rare chemicals and biologics necessary for drug discovery are a huge distraction for R&D labs. Learn from the perspectives of industry executives the pain points and improvements they want in their processes for chemicals and biologics in pharmaceuticals R&D. Sponsored by: Kinaxis Download this life sciences industry spotlight to discover how concurrent planning can help you overcome complex supply chain challenges to drive down costs and improve efficiency. Sponsored by: Catalent Download the case study to learn about the clinical supply management tools that helped a small sized pharma company during phase III of a multi-arm oncology study. Sponsored by: Catalent Watch a short video on demand led supply model. It is designed to meet the needs of patients, clinical sites, clinical team and sponsors and results in shorter lead time, less waste, less stock out risk and no booklet labels. Sponsored by: Catalent Download the eBook to explore a proactive approach for clinical supply management. | 
.jpg/BioNTech_Headquarters%20(1).jpg/8ef1fe43e13d5c7f936eb1b0e356eb76)
